My Florida Marketplace #EXP2666 AD

Single Source Procurement of bioLytical INSTI HIV-1/HIV-2 Rapid Test Devices and Training for Florida DOH

The Florida Department of Health (DOH), Bureau of Communicable Diseases, HIV/AIDS Section, is seeking a single source contract for rapid HIV testing solutions. - Government Buyer: - Florida Department of Health, Bureau of Communicable Diseases, HIV/AIDS Section - OEM Highlight: - bioLytical is the sole FDA-approved manufacturer of the INSTI HIV-1/HIV-2 Antibody Test devices - Products/Services Requested: - INSTI HIV-1/HIV-2 Antibody Test devices (FDA-approved, 3rd Generation, CLIA waived, rapid point-of-care, results in 60 seconds) - Training kits and services for public health staff on device usage - Quantities: - Not specified in the notice - Unique/Notable Requirements: - Only FDA-approved, CLIA-waived, 3rd Generation rapid HIV test accepted - bioLytical is the exclusive provider able to meet these requirements for public health and governmental entities - Training for staff is included as part of the procurement - Estimated contract value: $3,000,000 - Place of performance and delivery: Tallahassee, FL (Florida Department of Health offices at 4052 Bald Cypress Way and 2585 Merchants Row Blvd.)

Description

The Florida Department of Health (DOH) is seeking to enter into a single source contract for the bioLytical INSTI HIV-1/HIV-2 Antibody Test, a 3rd Generation HIV rapid point of care test that provides results in 60 seconds. This FDA-approved, CLIA waived device is unique in its rapid testing capability and is intended for use by the Bureau of Communicable Diseases, HIV/AIDS Section to serve at-risk communities. The procurement includes the purchase of testing devices and training kits. The total price for this single source contract is $3,000,000.00.

View original listing